Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
Evaluate efficacy, ie, sustained virologic response 12 weeks after the end of treatment (SVR12), of a combination treatment with AL-335, ODV, and SMV for 6 and 8 weeks in chronic HCV genotype 1, 2, 4, 5, or 6 infected subjects without cirrhosis
Inclusion criteria
- Chronic hepatitis C virus infection